
Neal Dave, PharmD, the executive director of pharmacy at Texas Oncology, discussed physician anticipation for the first biosimilars for programmed death (PD)-1 inhibitors.

Neal Dave, PharmD, the executive director of pharmacy at Texas Oncology, discussed physician anticipation for the first biosimilars for programmed death (PD)-1 inhibitors.

Even though respondents did not know very much about spinal muscular atrophy, the survey showed that most were in favor of newborn screening.

STEP findings build on those from the SPRINT trial, seemingly confirming that intensive treatment for hypertension can reduce the risk of serious adverse cardiovascular (CV) outcomes. However, there was no significant benefit toward risk for all-cause and CV-related mortality.

Native American and Black youth aged 10 to 19 years had the highest incidence of type 2 diabetes overall.

Many young people develop resistance to antiretroviral treatment or they experience lipoatrophy; many also have metabolic complications or inflammation via immune activation, noted Allison Agwu, MD, ScM, FAAP, FIDSA, Johns Hopkins University School of Medicine.

The study, using a BCR/ABL1 assay, found that the novel method is able to detect minimal residual disease (MRD) in a larger range of patients compared with quantitative real‐time polymerase chain reaction, the method currently used to detect MRD.

Findings of a recent review highlight the potential role nutrition can play in pediatric migraine.

Hilary Pinnock, MD, talks about what her session at the European Respiratory Society International Congress 2021 will cover and other sessions that she's excited to check out.

The approval of zanubrutinib makes it just the second therapy indicated for this rare type of lymphoma.

Tonya Winders, MBA, CEO and president of the Allergy & Asthma Network, highlights what she is looking forward to at the European Respiratory Society (ERS) International Congress 2021.

Findings indicate that youth with type 1 diabetes may benefit from limiting fat intake.

Highlighting the latest ophthalmology-related news reported across MJH Life Sciences™.

The Supreme Court rules to allow Texas to keep strict abortion law; the family behind Purdue Pharma has been granted immunity from future lawsuits related to the opioid crisis; Pfizer and Merck start trials for oral COVID-19 drugs.

Using whole genome sequencing, copy number signatures were successful in predicting both the presence of chromothripsis and clinical outcomes in patients with newly diagnosed multiple myeloma (MM).

The findings of this study suggest possible poor communication about human papillomavirus infection (HPV), the authors said, since they do not align with epidemiologic evidence.

By year 5 of therapy with disease-modifying anti-rheumatic drugs (DMARDs), only about one-third of patients with psoriatic arthritis (PsA) were expected to be continuing with their therapy.

Patients who have both multiple sclerosis (MS) and depression may have a higher risk of death and vascular disease compared with people who only have 1 or neither of those conditions.

People who suffered trauma as a child appear to be at a higher risk of fibromyalgia, although it is unclear exactly why.

Patients with systemic lupus erythematosus (SLE) said they still suffered significant pain and fatigue, even though they reported high rates of satisfaction with their therapies.

A new Texas law ending abortions after 6 weeks takes effect, angering the American College of Obstetricians and Gynecologists; the CDC says mortality rates may not go back to normal until 2023; a Senate version of a bill aimed at lowering drug prices would only impact Medicare.

The findings, if confirmed in subsequent research, could prove to have significant implications, as only a small subset of patients with chronic lymphocytic leukemia (CLL) respond to chimeric antigen receptor (CAR) T-cell therapy.

The European Respiratory Society International Congress 2021 will feature a wide array of topics, such as gender and respiratory health, the impact of climate change, and management and treatment of chronic cough, but there remains a strong focus on the COVID-19 pandemic, its intersection with respiratory care and treatment of infection.

This new analysis aimed to pinpoint more rigorous predictors of mortality, and it was able to identify “excellent” but not “outstanding” ones, according to the investigators.

This study protocol comes amid a paradigm shift in the treatment of advanced-stagen non–small cell lung cancer (NSCLC) following the emergence and uptake of immunotherapy.

Increasing the dosage of timolol-dorzolamide fixed combination from twice a day to 3 times a day was found to be safe and significantly more effective in reducing intraocular pressure in patients with open-angle glaucoma, although further research on safety may be warranted.

Results of a multicenter study showed 43% of patients with advanced melanoma treated with anti–programmed cell death 1 therapy experienced chronic complications.

On this episode of Managed Care Cast, we speak with Ellen Kelsay, president and CEO of the Business Group on Health, on the findings from her organization's 2022 Large Employers’ Health Care Strategy and Plan Design Survey.

HHS establishes the Office of Climate Change and Health Equity; Johnson & Johnson HIV vaccine fails mid-stage trial in sub-Saharan African women; prevalence of overweight and obesity increases significantly in children and adolescents amid the COVID-19 pandemic.

Ezio Bonifacio, PhD, describes the benefits of screening children for type 1 diabetes and what preventive interventions may be possible.

Patients with idiopathic Parkinson disease given Origanum majorana tea in combination with conventional medication exhibited significant improvements in depressive and nonmotor symptom burden vs placebo, although improvement of motor symptoms was not significant.

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512
© 2025 MJH Life Sciences®
All rights reserved.
